Prognostic value of XIAP and survivin expression in locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy

INTRODUCTION: Neoadjuvant treatment in locally advanced breast cancer (LABC) is intended to decrease the cancer mass, increase the likelihood of radical resection and improve survival. Resistance to chemotherapy may depend on cellular expression of anti-apoptotic proteins. XIAP and survivin are the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pluta, Piotr, Jesionek-Kupnicka, Dorota, Pluta, Agnieszka, Brzozowski, Kamil, Braun, Marcin, Kubicka-Wołkowska, Joanna, Piekarski, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074301/
https://www.ncbi.nlm.nih.gov/pubmed/37034529
http://dx.doi.org/10.5114/aoms.2019.88509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074301/
https://www.ncbi.nlm.nih.gov/pubmed/37034529
http://dx.doi.org/10.5114/aoms.2019.88509

Ejemplares similares